2024 has turned out to be a great year for Roblox (NYSE: RBLX) as its stock price rose 25% year to date (as of writing), reaching a level not seen since 2022. While there is general optimism in the stock market, company-specific reasons remain the biggest drivers of Roblox’s solid …
Read More »Markets
Down 61% From Its All-Time High, Could This Beaten-Down Dividend King Stock Finally Turn the Corner in 2025?
Stanley Black & Decker (NYSE: SWK) is a tool-maker titan. It owns well-known brands DeWalt, Craftsman, Irwin, and LENOX, and, of course, Stanley and Black & Decker. But the stock has been in the doghouse. It’s down 61.7% from its all-time high (reached in 2021) and up less than 21% …
Read More »Motley Fool Money’s 2024 Energy Review
In this podcast, Motley Fool analyst Nick Sciple joins host Ricky Mulvey for a conversation on the biggest energy stories of the past year. They also discuss: How the US has gotten more efficient at extracting oil from the ground. The challenges facing companies hoping to build small nuclear reactors. …
Read More »UnitedHealth Confirms Killer Of CEO Brian Thompson And His Parents Was Not Company Member
(RTTNews) – UnitedHealth Group Inc. (UNH) stated that a person responsible for the murder of Chief Executive officer Brian Thompson and his parents were not members of the company. The company continues to collaborate closely with law enforcement in the investigation of this horrific crime. UnitedHealthcare reported that it approves …
Read More »FDA Oks Checkpoint Therapeutics’ UNLOXCYT For Advanced Cutaneous Squamous Cell Carcinoma treatment
(RTTNews) – Checkpoint Therapeutics Inc. (CKPT) announced that the U.S. Food and Drug Administration (FDA) has approved UNLOXCYT(cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation. UNLOXCYT is the first and only …
Read More »Neurocrine’s CRENESSITY Gains FDA Approval For Treating Congenital Adrenal Hyperplasia
(RTTNews) – Neurocrine Biosciences, Inc. (NBIX) said that the U.S. Food and Drug Administration has approved CRENESSITY (crinecerfont) capsules and oral solution as an adjunctive treatment to glucocorticoid replacement to control androgens in adult and pediatric patients four years of age and older with classic congenital adrenal hyperplasia (CAH), a …
Read More »Netflix’s Unyielding Dominance: How This Streaming Giant Continues to Outpace Competitors
Explore the exciting world of Netflix (NASDAQ: NFLX) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of Oct. 30, 2024. Source link
Read More »Why Alaska Air Stock Surged 15% Higher This Week
A business update was the main news powering Alaska Air(NYSE: ALK) stock to a double-digit gain over the past few trading days. During the week, the carrier’s shares rose by just over 15% in price, according to data compiled by S&P Global Market Intelligence. Accelerating into the future On Tuesday, …
Read More »Could Super Micro Computer Stock Be the Comeback Story of 2025?
Super Micro Computer (NASDAQ: SMCI) has been one of the most polarizing stocks to own this year. It started out as a hot artificial intelligence (AI) company with mammoth potential, but it has recently become a risky investment with questionable and potentially inflated numbers due to poor accounting controls and …
Read More »Can Bitcoin Get to $200,000 in 2025?
Just a few years ago, Bitcoin (CRYPTO: BTC) reaching $100,000 seemed like a long shot — but it happened. And now, the next potential target investors have their eyes on is $200,000. While I did predict Bitcoin would reach $100,000 in 2024, the reality is that no one knows exactly …
Read More »